フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
ics PLC - novel RNA therapeutics developer with offices in London and Berlin - Says last day of trading of shares on A ...
Silence Therapeutics PLC 26 November 2021 Silence Therapeutics plc: Update on AIM Delisting 26 November 2021 LONDON, Silence Therapeutics plc...
FTSE Russell 25 November 2021 Silence Therapeutics (UK): Constituent Deletion Changes in FTSE UK Index Series 25 November 2021 Subject to the...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Silence Therapeutics PLC 16 November 2021 Silence Therapeutics Reports Third Quarter 2021 Financial Results 16 November 2021 LONDON, Silence...
Silence Therapeutics PLC 11 November 2021 Silence Therapeutics to Present at Jefferies London Healthcare Conference 11 November 2021 LONDON...
Silence Therapeutics PLC 10 November 2021 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B9GTXM62 Issuer Name...
ics PLC - novel RNA therapeutics developer with offices in London and Berlin - Investment firm Frazier Life Sciences P ...
Silence Therapeutics PLC 05 November 2021 Silence Therapeutics Welcomes Frazier Life Sciences as New Key Shareholder 5 November 2021 LONDON...
Silence Therapeutics PLC 01 November 2021 Results of General Meeting 1 November 2021 LONDON, Silence Therapeutics plc, AIM:SLN and Nasdaq:SLN...
Silence Therapeutics PLC 01 November 2021 Additional listing and Total Voting Rights 1 November 2021 LONDON, Silence Therapeutics plc, AIM:SLN and...
Silence Therapeutics PLC 28 October 2021 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
ics PLC - novel RNA therapeutics developer with offices in London and Berlin - Says it plans to initiate a Phase 1 stu ...
Silence Therapeutics PLC 21 October 2021 Silence Therapeutics Provides mRNAi GOLD(TM) Platform and Pipeline Updates at 2021 R&D Day...
arify Hansoh Pharmaceuticals Group will make an upfront payment to Silence Therapeutics PLC of USD16 million, not the ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す